In conclusion, our current study provided the evidence that Guchang capsule could ameliorate DSS-induced colitis and illustrated its potential mechanism by inhibiting NF-κB activation through regulating expression of NF-κB related lncRNAs. Here, NFKB1 is linked to colitis.